Skip to main content
Erschienen in: Pädiatrie 6/2014

28.11.2014 | Zertifizierte Fortbildung

Mutationen im SHOX-Gen

Häufige Form des Kleinwuchses

verfasst von: Prof. Dr. Gudrun A. Rappold

Erschienen in: Pädiatrie | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Zusammenfassung

Untersuchungen ergaben, dass bis zu 17 % der kleinwüchsigen Kinder von Veränderungen im SHOX-Gen betroffen sind. SHOX steht für „short stature homeobox“. Klinische Zeichen wie Dysproportionen oder Deformitäten bilden sich häufig erst später im Leben der Kinder aus, sodass fälschlicherweise die Diagnose eines „idiopathischen Kleinwuchses“ gestellt wird.
Literatur
1.
Zurück zum Zitat Benito-Sanz S, Thomas NS, Huber C, et al. A novel class of Pseudoautosomal region 1 deletions downstream of SHOX is associatedwith Leri-Weill dyschondrosteosis.AmJHumGenet. 2005;77:533–544 Benito-Sanz S, Thomas NS, Huber C, et al. A novel class of Pseudoautosomal region 1 deletions downstream of SHOX is associatedwith Leri-Weill dyschondrosteosis.AmJHumGenet. 2005;77:533–544
2.
Zurück zum Zitat Binder G, Renz A, Martinez A, et al. SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity. J Clin Endocrinol Metab. 2004;89:4403–4408PubMedCrossRef Binder G, Renz A, Martinez A, et al. SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity. J Clin Endocrinol Metab. 2004;89:4403–4408PubMedCrossRef
3.
Zurück zum Zitat Binder G. Short stature due to SHOX deficiency: genotype, phenotype, and therapy. Horm Res Paediatr. 2011;75:81–89PubMedCrossRef Binder G. Short stature due to SHOX deficiency: genotype, phenotype, and therapy. Horm Res Paediatr. 2011;75:81–89PubMedCrossRef
4.
Zurück zum Zitat Blum WF, Crowe BJ, Quigley CA et al. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: two-year results of a randomized, controlled, multicenter trial. J Clin Endocrinol Metab. 2007;92:219–228PubMedCrossRef Blum WF, Crowe BJ, Quigley CA et al. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: two-year results of a randomized, controlled, multicenter trial. J Clin Endocrinol Metab. 2007;92:219–228PubMedCrossRef
5.
Zurück zum Zitat Blum WF, Cao D, Hesse V, et al. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome. Horm Res. 2009;71:167–172PubMedCrossRef Blum WF, Cao D, Hesse V, et al. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome. Horm Res. 2009;71:167–172PubMedCrossRef
6.
Zurück zum Zitat Blum WF, Ross JL, Zimmermann AG, Quigley CA, Child CJ, Kalifa G, Deal C, Drop SL, Rappold G, Cutler GB Jr. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial. J Clin Endocrinol Metab 2013; 98: E1383–1392CrossRef Blum WF, Ross JL, Zimmermann AG, Quigley CA, Child CJ, Kalifa G, Deal C, Drop SL, Rappold G, Cutler GB Jr. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial. J Clin Endocrinol Metab 2013; 98: E1383–1392CrossRef
7.
Zurück zum Zitat Chen J, Wildhardt G, Zhong Z, et al. Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domain. J Med Genet. 2009;46: 834–839PubMedCentralPubMedCrossRef Chen J, Wildhardt G, Zhong Z, et al. Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domain. J Med Genet. 2009;46: 834–839PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Durand C, Bangs F, Signolet J, Decker E, Tickle C, Rappold G. Enhancer elements upstream of the SHOX gene are active in the developing limb. Eur J Hum Genet. 2010;18:527–532PubMedCentralPubMedCrossRef Durand C, Bangs F, Signolet J, Decker E, Tickle C, Rappold G. Enhancer elements upstream of the SHOX gene are active in the developing limb. Eur J Hum Genet. 2010;18:527–532PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Fukami M, Nishi Y, Hasegawa Y, et al. Statural growth in 31 Japanese patients with SHOX haploinsufficiency: support for a disadvantageous effect of gonadal estrogens. Endocr J. 2004;51:197–200PubMedCrossRef Fukami M, Nishi Y, Hasegawa Y, et al. Statural growth in 31 Japanese patients with SHOX haploinsufficiency: support for a disadvantageous effect of gonadal estrogens. Endocr J. 2004;51:197–200PubMedCrossRef
10.
Zurück zum Zitat Kemp SF, Kuntze J, Attie KM, et al. Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature. J Clin Endocrinol Metab. 2005;90:5247–5253PubMedCrossRef Kemp SF, Kuntze J, Attie KM, et al. Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature. J Clin Endocrinol Metab. 2005;90:5247–5253PubMedCrossRef
11.
Zurück zum Zitat Kosho T, Muroya K, Nagai T, et al. Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome. J Clin Endocrinol Metab. 1999;84: 4613–4621PubMedCrossRef Kosho T, Muroya K, Nagai T, et al. Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome. J Clin Endocrinol Metab. 1999;84: 4613–4621PubMedCrossRef
12.
Zurück zum Zitat Leschek EW, Rose SR, Yanovski JA, et al. Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:3140–3148PubMedCrossRef Leschek EW, Rose SR, Yanovski JA, et al. Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:3140–3148PubMedCrossRef
13.
Zurück zum Zitat Marchini A, Rappold G, Schneider KU. SHOX at a glance: from gene to protein. Arch Physiol Biochem. 2007;113:116–123PubMedCrossRef Marchini A, Rappold G, Schneider KU. SHOX at a glance: from gene to protein. Arch Physiol Biochem. 2007;113:116–123PubMedCrossRef
14.
Zurück zum Zitat Rao E, Weiss B, Fukami M, et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet. 1997;16:54–63PubMedCrossRef Rao E, Weiss B, Fukami M, et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet. 1997;16:54–63PubMedCrossRef
15.
Zurück zum Zitat Rappold GA, Fukami M, Niesler B, et al. Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature. J Clin Endocrinol Metab. 2002;87:1402–1406PubMedCrossRef Rappold GA, Fukami M, Niesler B, et al. Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature. J Clin Endocrinol Metab. 2002;87:1402–1406PubMedCrossRef
16.
Zurück zum Zitat Rappold G, Blum WF, Shavrikova EP, et al. Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency. J Med Genet. 2007;44:306–313PubMedCentralPubMedCrossRef Rappold G, Blum WF, Shavrikova EP, et al. Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency. J Med Genet. 2007;44:306–313PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Ross JL, Kowal K, Quigley CA, et al. The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome. J Pediatr. 2005;147:499–507PubMedCrossRef Ross JL, Kowal K, Quigley CA, et al. The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome. J Pediatr. 2005;147:499–507PubMedCrossRef
18.
Metadaten
Titel
Mutationen im SHOX-Gen
Häufige Form des Kleinwuchses
verfasst von
Prof. Dr. Gudrun A. Rappold
Publikationsdatum
28.11.2014
Verlag
Urban & Vogel
Erschienen in
Pädiatrie / Ausgabe 6/2014
Print ISSN: 1867-2132
Elektronische ISSN: 2196-6443
DOI
https://doi.org/10.1007/s15014-014-0505-2

Weitere Artikel der Ausgabe 6/2014

Pädiatrie 6/2014 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.